{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:40:03Z","timestamp":1749685203302,"version":"3.41.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.041","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T15:01:26Z","timestamp":1478098886000},"page":"6367-6374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection"],"prefix":"10.1016","volume":"34","author":[{"given":"Michael M.","family":"Pieler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Frentzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunja","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.041_b0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00253-006-0675-0","article-title":"Magnetic particles for the separation and purification of nucleic acids","volume":"73","author":"Berensmeier","year":"2006","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2016.10.041_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-044X-2-7","article-title":"Magnetic techniques for the isolation and purification of proteins and peptides","volume":"2","author":"Safarik","year":"2004","journal-title":"Biomagn Res Technol"},{"key":"10.1016\/j.vaccine.2016.10.041_b0015","doi-asserted-by":"crossref","DOI":"10.1021\/acs.analchem.5b02681","article-title":"Comparison of influenza virus particle purification using novel magnetic sulfated cellulose particles with an established centrifugation method for analytics","author":"Serve","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2016.10.041_b0020","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bmc.2008.11.046","article-title":"Anionic polymer, poly(methyl vinyl ether\u2013maleic anhydride)-coated beads-based capture of human influenza A and B virus","volume":"17","author":"Sakudo","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.vaccine.2016.10.041_b0025","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1016\/j.bmcl.2009.05.127","article-title":"Use of anionic polymer, poly(methyl vinyl ether-maleic anhydride)-coated beads for capture of respiratory syncytial virus","volume":"19","author":"Sakudo","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.vaccine.2016.10.041_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-4347(98)00338-7","article-title":"Use of magnetic techniques for the isolation of cells","volume":"722","author":"\u0160afa\u0159\u0131\u0301k","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.vaccine.2016.10.041_b0035","series-title":"Functional Magnetic Particles for Medical Application. Recent Prog. Biochem. Biomed. Eng. Jpn. II","first-page":"191","author":"Shinkai","year":"2004"},{"key":"10.1016\/j.vaccine.2016.10.041_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1263\/jbb.100.1","article-title":"Medical application of functionalized magnetic nanoparticles","volume":"100","author":"Ito","year":"2005","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.vaccine.2016.10.041_b0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.041_b0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/wnan.88","article-title":"Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles","volume":"2","author":"Xiang","year":"2010","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.vaccine.2016.10.041_b0055","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1586\/erv.11.111","article-title":"Downstream processing of cell culture-derived virus particles","volume":"10","author":"Wolf","year":"2011","journal-title":"Expert Rev Vaccines"},{"year":"2014","series-title":"Vaccine development and manufacturing","author":"Wen","key":"10.1016\/j.vaccine.2016.10.041_b0060"},{"year":"2013","series-title":"Downstream industrial biotechnology: recovery and purification","author":"Flickinger","key":"10.1016\/j.vaccine.2016.10.041_b0065"},{"key":"10.1016\/j.vaccine.2016.10.041_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chroma.2015.01.007","article-title":"Downstream processing of virus-like particles: single-stage and multi-stage aqueous two-phase extraction","volume":"1383","author":"Ladd Effio","year":"2015","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2016.10.041_b0075","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/bit.22797","article-title":"Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography","volume":"107","author":"Wolff","year":"2010","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2016.10.041_b0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/bit.22595","article-title":"Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers","volume":"105","author":"Wolff","year":"2010","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2016.10.041_b0085","series-title":"Glycans Dis. Ther.","first-page":"31","article-title":"Heparan sulfate proteoglycans in infection","author":"Bartlett","year":"2011"},{"key":"10.1016\/j.vaccine.2016.10.041_b0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jbm.820230110","article-title":"Tissue biocompatibility of cellulose and its derivatives","volume":"23","author":"Miyamoto","year":"1989","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.vaccine.2016.10.041_b0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jbm.a.30570","article-title":"In vivo biocompatibility of bacterial cellulose","volume":"76A","author":"Helenius","year":"2006","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.vaccine.2016.10.041_b0100","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0142-9612(01)00152-1","article-title":"Cellulose phosphates as biomaterials. In vivo biocompatibility studies","volume":"23","author":"Fricain","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2016.10.041_b0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.memsci.2008.03.030","article-title":"Fabrication and bioseparation studies of adsorptive membranes\/felts made from electrospun cellulose acetate nanofibers","volume":"319","author":"Zhang","year":"2008","journal-title":"J Membr Sci"},{"key":"10.1016\/j.vaccine.2016.10.041_b0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biologicals.2007.10.002","article-title":"Monitoring influenza virus content in vaccine production: Precise assays for the quantitation of hemagglutination and neuraminidase activity","volume":"36","author":"Kalbfuss","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2016.10.041_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J Biol Stand"},{"issue":"35","key":"10.1016\/j.vaccine.2016.10.041_b0120","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1016\/j.vaccine.2015.02.077","article-title":"Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension","volume":"33","author":"Kluge","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.041_b0125","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1016\/j.vaccine.2010.07.004","article-title":"A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor","volume":"28","author":"Lohr","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.041_b0130","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/j.vaccine.2013.09.051","article-title":"Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line","volume":"31","author":"Peschel","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.041_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/bit.21139","article-title":"Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines","volume":"97","author":"Kalbfuss","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2016.10.041_b0140","unstructured":"Wolff M, Pieler MM, Reichl U. Process for the preparation of magnetic sulfated cellulose particles, magnetic sulfated cellulose particles and its use. EP14175925, n.d."},{"key":"10.1016\/j.vaccine.2016.10.041_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00214","article-title":"Vaccine adjuvants: mode of action","volume":"4","author":"De Gregorio","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.10.041_b0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jviromet.2009.06.025","article-title":"Purification of cell culture-derived influenza virus A\/Puerto Rico\/8\/34 by membrane-based immobilized metal affinity chromatography","volume":"161","author":"Opitz","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.10.041_b0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.10.041_b0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/elps.1150080203","article-title":"Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels","volume":"8","author":"Blum","year":"1987","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2016.10.041_b0165","doi-asserted-by":"crossref","first-page":"e4840","DOI":"10.1371\/journal.pone.0004840","article-title":"Increased susceptibility for superinfection with streptococcus pneumoniae during Influenza virus infection is not caused by TLR7-mediated lymphopenia","volume":"4","author":"Stegemann","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.041_b0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0168-3659(98)00193-X","article-title":"Controlled release of a model protein from enzymatically degrading dextran microspheres","volume":"59","author":"Franssen","year":"1999","journal-title":"J Controll Rel"},{"key":"10.1016\/j.vaccine.2016.10.041_b0175","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1073\/pnas.1500408112","article-title":"Effective and lesion-free cutaneous influenza vaccination","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2016.10.041_b0180","doi-asserted-by":"crossref","first-page":"e10266","DOI":"10.1371\/journal.pone.0010266","article-title":"Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model","volume":"5","author":"Fernando","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.041_b0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejps.2015.02.005","article-title":"Animal models for cutaneous vaccine delivery","volume":"71","author":"Hirschberg","year":"2015","journal-title":"Eur J Pharm Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:25:42Z","timestamp":1749684342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16309768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":37,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16309768"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}